BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7745068)

  • 1. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.
    Dor J; Seidman DS; Amudai E; Bider D; Levran D; Mashiach S
    Hum Reprod; 1995 Jan; 10(1):40-3. PubMed ID: 7745068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3).
    Huang ZH; Baxter RC; Hughes SM; Matson PL; Lieberman BA; Morris ID
    Hum Reprod; 1993 Jun; 8(6):850-7. PubMed ID: 7688379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
    Homburg R; Levy T; Ben-Rafael Z
    Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization.
    Hughes SM; Huang ZH; Morris ID; Matson PL; Buck P; Lieberman BA
    Hum Reprod; 1994 Jan; 9(1):13-8. PubMed ID: 8195335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone.
    Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID
    Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization.
    Bergh C; Carlström K; Selleskog U; Hillensjö T
    Eur J Endocrinol; 1996 Feb; 134(2):190-6. PubMed ID: 8630518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
    Tsai HD; Chen CM; Lo HY; Chang CC
    Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin.
    Golan A; Herman A; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1994 Sep; 9(9):1631-3. PubMed ID: 7836512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.
    Eftekhar M; Aflatoonian A; Mohammadian F; Eftekhar T
    Arch Gynecol Obstet; 2013 May; 287(5):1017-21. PubMed ID: 23208461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of growth hormone on granulosa cell function during in-vitro fertilization.
    Younis JS; Ezra Y; Brzezinnski A; Fibich T; Schenker JG; Laufer N
    Hum Reprod; 1993 Oct; 8(10):1588-92. PubMed ID: 8300811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology.
    Suikkari A; MacLachlan V; Koistinen R; Seppälä M; Healy D
    Fertil Steril; 1996 Apr; 65(4):800-5. PubMed ID: 8654642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women.
    Hugues JN; Torresani T; Herve F; Martin-Pont B; Tamboise A; Santarelli J
    Fertil Steril; 1991 May; 55(5):945-51. PubMed ID: 1827076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial.
    Lee VC; Chan CC; Ng EH; Yeung WS; Ho PC
    Reprod Biomed Online; 2011 Sep; 23(3):380-8. PubMed ID: 21782514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.